Short Communication: Evaluation of Antiretroviral Drug Concentrations in Minimally Invasive Specimens for Potential Development of Point-of-Care Drug Assays
Open Access
- 11 October 2021
- journal article
- research article
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 37 (10) , 744-747
Abstract
Point-of-care (POC) tests for antiretroviral drugs (ARVs) could help improve individual adherence. This study sought to define the utility of urine, blood, and buccal swabs as minimally invasive specimens amenable to development of POC tests for ARVs. Urine, dried blood spots (DBS) and buccal swabs were collected from 35 HIV-negative men between 2 and 96 h after a single dose of tenofovir (TFV) alafenamide/emtricitabine (FTC)/elvitegravir (EVG)/cobicistat and darunavir (DRV). ARV concentrations were measured by high-performance liquid chromatography-mass spectrometry. High concentrations of FTC, DRV, and TFV were detectable in urine at least 24 h after dosing. FTC, DRV, and EVG remained detectable in DBS at least 24 h postdose. FTC and DRV were detectable on buccal swabs up to 2 and 24 h postdose, respectively. TFV was not detectable in DBS or buccal swabs collected between 2 and 96 h after dosing. Variable distribution of ARVs in minimally invasive specimens highlights the challenge of developing POC assays for recent ARV exposure.Keywords
This publication has 10 references indexed in Scilit:
- Tenofovir Urine Assay to Monitor Adherence to HIV Pre-exposure ProphylaxisCurrent Clinical Pharmacology, 2020
- Point-of-care and Near Real-time Testing for Antiretroviral Adherence Monitoring to HIV Treatment and PreventionCurrent HIV/AIDS Reports, 2020
- Low tenofovir level in urine by a novel immunoassay is associated with seroconversion in a preexposure prophylaxis demonstration projectAIDS, 2019
- Development and Validation of an Immunoassay for Tenofovir in Urine as a Real-Time Metric of Antiretroviral AdherenceeClinicalMedicine, 2018
- Antiretroviral Drugs for Treatment and Prevention of HIV Infection in AdultsJAMA, 2018
- Urine assay for tenofovir to monitor adherence in real time to tenofovir disoproxil fumarate/emtricitabine as pre‐exposure prophylaxisHIV Medicine, 2017
- A validated assay by liquid chromatography–tandem mass spectrometry for the simultaneous quantification of elvitegravir and rilpivirine in HIV positive patientsJournal of Mass Spectrometry, 2013
- Concentrations of Tenofovir and Emtricitabine in Saliva: Implications for Preexposure Prophylaxis of Oral HIV AcquisitionAntimicrobial Agents and Chemotherapy, 2011
- Effect of Mobile Phase pH and Organic Content on LC--MS Analysis of Nucleoside and Nucleotide HIV Reverse Transcriptase InhibitorsJournal of Chromatographic Science, 2009
- Radioimmunoassay for monitoring zidovudine in dried blood spot specimensClinical Chemistry, 1998